A detailed history of Mqs Management LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Mqs Management LLC holds 1,561 shares of CRL stock, worth $301,116. This represents 0.2% of its overall portfolio holdings.

Number of Shares
1,561
Holding current value
$301,116
% of portfolio
0.2%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$206.39 - $268.73 $322,174 - $419,487
1,561 New
1,561 $322,000
Q2 2023

Aug 10, 2023

BUY
$183.71 - $210.25 $347,579 - $397,793
1,892 New
1,892 $397,000
Q2 2022

Aug 05, 2022

BUY
$204.13 - $302.4 $386,418 - $572,443
1,893 Added 212.7%
2,783 $595,000
Q1 2022

May 10, 2022

SELL
$255.51 - $362.11 $84,062 - $119,134
-329 Reduced 26.99%
890 $253,000
Q4 2021

Feb 11, 2022

BUY
$351.38 - $448.68 $428,332 - $546,940
1,219 New
1,219 $459,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.81B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Mqs Management LLC Portfolio

Follow Mqs Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mqs Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mqs Management LLC with notifications on news.